NHS FORTH VALLEY Guidelines for Hepatitis B Vaccination in High Risk Groups

Size: px
Start display at page:

Download "NHS FORTH VALLEY Guidelines for Hepatitis B Vaccination in High Risk Groups"

Transcription

1 NHS FORTH VALLEY Guidelines for Hepatitis B Vaccination in High Risk Groups Approved 01/04/2012 Version 1.0 Date of First Issue 01/04/2012 Review Date 01/02/2014 Date of Issue 01/04/2012 EQIA Yes Author / Contact Juliet Tucker/ Debbie Forbes Group / Committee Final Approval Women & Children Clinical Governance Committee Version st April 2012 page 1 of 7

2 NHS Forth Valley Consultation and Change Record Contributing Authors: Consultation Process: Juliet Tucker Consultant Paediatricians NNU staff Distribution: FV Intranet NNU Change Record Date Author Change Version 28/10/10 JAT Update schedule according to comments/feedback 2.0 Version st April 2012 page 2 of 7

3 NHS Forth Valley Women & Children s Unit Hepatitis B Vaccination in High Risk Groups Table of Contents Table of Contents...3 Indications for vaccination...3 Antenatal management...4 Consent...4 Immunisation Schedule...4 Known Hepatitis B exposure (eg Maternal Hep B)...5 Adverse reactions...6 Discharge...6 Indications for vaccination All babies / children whose mothers have a history of past or present hepatitis B. Some babies will also require Hepatitis B immunoglobulin (See appropriate protocol). All babies / children born to mothers with past or present history of IV drug misuse irrespective of their mother's HBV status. All babies / children who will be a close household contact of any other person with a history of Hepatitis B infection or who has a past or current history of IV drug use. Also consider: Children living in residential care with learning difficulties where risk of biting or being bitten. Children travelling to high risk countries Children with chronic liver disease Children with chronic renal failure Children receiving regular blood products eg Haemophilia Vaccination should be offered to all those who fit these criteria. For newborns, the sooner the vaccination can be given the better. Vaccination is highly effective at preventing transmission if first dose given within 48 hours. Version st April 2012 page 3 of 7

4 Babies acquiring the virus through vertical transmission have a high chance of becoming chronically infected and so this is particularly important in those who have been exposed to maternal Hepatitis B or whose status is unknown. Flowchart: - Management of babies whose Parents have a history (past or present) of IV drug use regarding risk of Blood-Bourne Infection Antenatal management Risk of Hepatitis B and benefits of vaccination for the baby should be discussed with the mother antenatally a Department of Health information leaflet is available. For those at risk of Hepatitis B through lifestyle, antenatal screening for other blood borne infections including HIV and Hepatitis C should be completed and results documented antenatally and in baby notes after birth. Consent Consent must be obtained from a parent with parental rights or the local authority if consent to medical treatment has been granted by a court as a condition of a supervision requirement. Immunisation Schedule Hepatitis B vaccines are inactivated and so cannot cause the disease. It can be given at the same time as other vaccines but must be given in a different area, or at least 2.5cm apart if given in the same limb 1 There is evidence that the response to hepatitis B vaccine is lower in pre-term, low-birth weight babies 2. It is, therefore, important that premature infants receive the full paediatric dose of hepatitis B vaccine on schedule. Babies with a birthweight of 1500g or less, born to mothers infected with hepatitis B, should receive HBIG in addition to the vaccine, regardless of the e-antigen status of the mother. Hepatitis B immunoglobulin (HBIG) provides passive immunity to give intermediate protection after exposure until the hepatitis B vaccine becomes effective. It should be given at the same time as the hepatitis B vaccine but in the other thigh. It should be administered as soon as possible, and at least within 24h of birth. Immunisations are usually given as part of a 3 dose schedule with or without a fourth booster dose. This would only be given if known exposure or if schedule had been incomplete/out of timescales and titres low. The accelerated schedule can be used for prophylaxis if compliance is a concern. For teenagers between 11 and 15 years, a two dose schedule (at zero and six months) of the adult vaccine provides similar protection to three doses of the childhood vaccine. Administer 10 microgrammes Engerix B (0.5ml), by IM injection. Version st April 2012 page 4 of 7

5 For High Risk prophylaxis At birth At 1 month At 6 months For Hep B exposure (accelerated schedule) At birth At 1 month At 2 months Booster at 1 year if Booster at 1 year with exposure continues serology check Markers of infection / Response to vaccine Testing for markers of past or previous infection would only be clinically indicated in children of affected parents or if status is unknown in high risk groups. This should be done prior to the first vaccination. Checking antibody response following appropriately completed schedule is not routinely necessary in those vaccinated because of risk factors only. Where immunisation has been delayed beyond the recommended intervals, the vaccine course should be completed, but it is more likely that the child may become infected / have incomplete protection. In this instance, testing for HBsAg above the age of one year is particularly important. The full duration of protection afforded by hepatitis B vaccine has yet to be established 3. Levels of vaccine-induced antibody to hepatitis B decline over time, but there is evidence that immune memory can persist in those successfully immunised 4. However, recent evidence suggests that not all individuals may respond in this way 5,6. It is, therefore, recommended that individuals at continuing risk of infection should be offered a single booster dose of vaccine, once only, around five years after primary immunisation. Measurement of anti-hep B levels is not required either before or after this dose. Boosters are also recommended after exposure to the virus. Known Hepatitis B exposure (eg Maternal Hep B) * (See Hep B protocol for Hep B positive mothers) For those who are given the vaccination because of known Hep B exposure, inform parent/guardian that testing for HBsAg at one year of age will be performed. Version st April 2012 page 5 of 7

6 This will identify any babies for whom this intervention has not been successful and who have become chronically infected with hepatitis B, and will allow them to be referred for assessment and any further management. This testing can be carried out at the same time as the fourth dose is given. Adverse reactions Hepatitis B vaccine is generally well tolerated and the most common adverse reactions are soreness and redness at the injection site. Other reactions that have been reported but may not be causally related include fever, rash, malaise and an influenza-like syndrome, arthritis, arthralgia, myalgia and abnormal liver function tests. Hepatitis B Immunoglobulin (HBIG) is well tolerated. Very rarely, anaphylactoid reactions occur in individuals with hypogammaglobulinaemia who have IgA antibodies, or those who have had an atypical reaction to blood transfusion. Discharge Ensure consent is documented and whether vaccine was given. Document relevant dates for when the vaccine was given and when the immunisations are due at 1 month and 6 months of age. Ensure antenatal screening results for HepB, Hep C and HIV documented. The information should be documented in the child s notes and communicated to primary care at discharge to ensure continuity of the schedule in the community. If child is looked after i.e in foster care placement ensure correspondence sent to child s own GP which may differ from Mums. Also send copy of discharge to: Administrator - Catherine Tannahill, Looked After Children s Health Team, St. Ninians Health Centre, Mayfield St, Stirling, FK70BS. Tel: References (Guidance largely extracted from The Department of Health - The Green Book 2006 updated Nov 2010) Also see FV Guidance for infants of Hep B positive mothers (draft 2010) 1. American Academy of Pediatrics, Losonsky et al., Whittle et al., Liao et al., 1999 Version st April 2012 page 6 of 7

7 5. Williams et al., Boxall et al., 2004 Publications in Alternative Formats NHS Forth Valley is happy to consider requests for publications in other language or formats such as large print. To request another language for a patient, please contact For other formats contact , text , fax or - Version st April 2012 page 7 of 7

Document title: Hepatitis B Neonatal and Infant Protocols. Verified by: Matthew Dominey, Screening and Immunisation Manager

Document title: Hepatitis B Neonatal and Infant Protocols. Verified by: Matthew Dominey, Screening and Immunisation Manager South West PHE Screening and Immunisation Team Good Practice Guidance for the management of the NHS Hepatitis B Neonatal and Infant Immunisation Programme Document title: Hepatitis B Neonatal and Infant

More information

NHS FORTH VALLEY. Administration of VZIG in close contact with chicken pox or shingles in a pregnant woman. Unit Clinical Governance

NHS FORTH VALLEY. Administration of VZIG in close contact with chicken pox or shingles in a pregnant woman. Unit Clinical Governance NHS FORTH VALLEY Date of First Issue 01/04/2006 Approved 05/05/2012 Current Issue Date 18/09/2012 Review Date 18/09/2016 Version 1.2 EQIA Yes 01/04/2012 Author / Contact Group Committee Final Approval

More information

William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016

William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016 William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016 Advisory Committee on Immunization Practices (ACIP) The recommendations to be discussed are primarily those of the ACIP composed of 15

More information

NHS FORTH VALLEY. Chickenpox in Pregnancy

NHS FORTH VALLEY. Chickenpox in Pregnancy NHS FORTH VALLEY Date of First Issue 13/12/2016 Approved 01/12/2016 Current Issue Date 13/12/2016 Review Date 01/10/2018 Version 1.0 EQIA Yes 13/12/2016 Author / Contact Dr N Miller/Kirsty MacInnes Group

More information

NOTIFIABLE. Infectious Disease Assessment for Migrants 2015 - 27 - RECOMMENDATIONS. Offer test (HBsAg and anti-hbc) to: Vaccinate:

NOTIFIABLE. Infectious Disease Assessment for Migrants 2015 - 27 - RECOMMENDATIONS. Offer test (HBsAg and anti-hbc) to: Vaccinate: 5.2 Hepatitis B NOTIFIABLE RECOMMENDATIONS Offer test (HBsAg and anti-hbc) to: = All new migrants originating from countries with a HBsAg prevalence of 2% = Household and sexual of identified acute or

More information

Patient Group Direction for the Administration of Hepatitis B vaccine

Patient Group Direction for the Administration of Hepatitis B vaccine Patient Group Direction for the Administration of Hepatitis B vaccine This PGD must be read in conjunction with the core PGD (Reference: NHSE(LR)/PGD/Core PGD for Immunisations), which details information

More information

Effectiveness of newborn hepatitis B vaccination programmes

Effectiveness of newborn hepatitis B vaccination programmes Effectiveness of newborn hepatitis B vaccination programmes Francis E André Consultant in Vaccinology Belgium Istanbul, March 15, 2006 Hepatitis B Perinatal Transmission If mother positive for HBsAg and

More information

Notes Prevention of and Immunisation against Hepatitis B and C

Notes Prevention of and Immunisation against Hepatitis B and C Prevention opportunities arise all the time, brief interventions are useful. Written back up material should be used. People may not be aware of the risk of sharing injecting equipment other than needles

More information

NHS FORTH VALLEY. Varicella Care Pathway for GPs

NHS FORTH VALLEY. Varicella Care Pathway for GPs NHS FORTH VALLEY Date of First Issue 01/04/2006 Approved 05/05/2012 Current Issue Date 28/04/2014 Review Date 28/04/2016 Version 1.2 EQIA Yes 01/04/2012 Author / Contact Debbie Forbes Group Committee Unit

More information

Hepatitis A The Basics

Hepatitis A The Basics HEPATITIS A VIRUS Hepatitis A The Basics Patrick Lynch, MD Assistant Professor of Medicine Northwestern University HEPATITIS A - CLINICAL FEATURES Jaundice by

More information

Vana Papaevangelou Pediatric ID specialist Athens, Greece

Vana Papaevangelou Pediatric ID specialist Athens, Greece Hepatitis B vaccination and HBIG administration policies implemented for premature babies; Vaccines concurrently administered with the hepatitis B vaccine birth dose Vana Papaevangelou Pediatric ID specialist

More information

HEPATITIS B VACCINATION KIT

HEPATITIS B VACCINATION KIT THE UNIVERSITY OF SOUTHERN INDIANA HEPATITIS B VACCINATION KIT Please bring this booklet to your scheduled Hepatitis B Vaccination appointment and present to your physician. Environmental Health and Safety

More information

ROYAL HOSPITAL FOR WOMEN

ROYAL HOSPITAL FOR WOMEN HEPATITIS B POSITIVE MOTHERS AND THEIR BABIES This LOP is developed to guide clinical practice at the Royal Hospital for Women. Individual patient circumstances may mean that practice diverges from this

More information

Hepatitis A. Contraindications. General. Hepatitis A vaccines (WHO position paper)

Hepatitis A. Contraindications. General. Hepatitis A vaccines (WHO position paper) Contraindications Contraindications to hepatitis A vaccination include a known allergy to any of the vaccine components. General Currently, four inactivated vaccines against HAV are internationally available.

More information

Hepatitis B vaccination patient passport

Hepatitis B vaccination patient passport Hepatitis B vaccination patient passport Delivering the best in care UHB is a no smoking Trust To see all of our current patient information leaflets please visit www.uhb.nhs.uk/patient-information-leaflets.htm

More information

Infection Prevention and Control Team (IPCT) GUIDELINES FOR STAFF WHO COME INTO CONTACT WITH VARICELLA ZOSTER VIRUS (CHICKENPOX OR SHINGLES)

Infection Prevention and Control Team (IPCT) GUIDELINES FOR STAFF WHO COME INTO CONTACT WITH VARICELLA ZOSTER VIRUS (CHICKENPOX OR SHINGLES) Infection Prevention and Control Team (IPCT) GUIDELINES FOR STAFF WHO COME INTO CONTACT WITH VARICELLA ZOSTER VIRUS (CHICKENPOX OR SHINGLES) WARNING This document is uncontrolled when printed. Check local

More information

Hepatitis B Pathway stages to protection Actions, roles, responsibilities and standards

Hepatitis B Pathway stages to protection Actions, roles, responsibilities and standards Hepatitis B Pathway stages to protection Actions, roles, responsibilities and standards Start Pathway stages colour code: Action Midwifery role Risk areas Specialist services role Primary care role Paediatric

More information

Hepatitis B. You and Your Baby

Hepatitis B. You and Your Baby You and Your Baby Hepatitis B If you have hepatitis B and you are pregnant, planning a pregnancy, if you've just had a baby or have children already, this leaflet will give you information on how to protect

More information

HEPATITIS B VACCINE. What is the difference between Hepatitis A, Hepatitis B, and Hepatitis C?

HEPATITIS B VACCINE. What is the difference between Hepatitis A, Hepatitis B, and Hepatitis C? HEPATITIS B VACCINE Overview What is hepatitis? Hepatitis means inflammation of the liver. Toxins, certain drugs, some diseases, heavy alcohol use, and bacterial and viral infections can all cause hepatitis.

More information

Hepatitis B in Pregnancy

Hepatitis B in Pregnancy Hepatitis B in Pregnancy This guideline was updated in July 2015 by Dr Joana de Sousa, with input from members of the New Zealand Maternal Fetal Medicine Network and Neonatology. Background It is recognised

More information

NATIONAL PATIENT GROUP DIRECTION FOR SUPPLY OF PARACETAMOL ORAL SUSPENSION

NATIONAL PATIENT GROUP DIRECTION FOR SUPPLY OF PARACETAMOL ORAL SUSPENSION NATIONAL PATIENT GROUP DIRECTION FOR SUPPLY OF PARACETAMOL ORAL SUSPENSION 120 mg/5ml FOR PREVENTION OF POST IMMUNISATION FEVER FOLLOWING ADMINISTRATION OF MENINGOCOCCAL GROUP B VACCINE (BEXSERO ) BY AUTHORISED

More information

HEPATITIS B The Importance of the Hepatitis B Vaccine

HEPATITIS B The Importance of the Hepatitis B Vaccine HEPATITIS B The Importance of the Hepatitis B Vaccine Since 1982, a hepatitis B vaccine has been available to prevent hepatitis B virus infection. Today, the vaccine is made using recombinant DNA technology

More information

Perinatal Hepatitis B Case Management Massachusetts Department of Public Health Immunization Program

Perinatal Hepatitis B Case Management Massachusetts Department of Public Health Immunization Program Perinatal Hepatitis B Case Management 2014 Massachusetts Department of Public Health Immunization Program Outline Overview of hepatitis B disease burden Prevalence of perinatal transmission of hepatitis

More information

Patient Group Direction for the Administration of Combined Hepatitis A and Hepatitis B vaccine

Patient Group Direction for the Administration of Combined Hepatitis A and Hepatitis B vaccine Patient Group Direction for the Administration of Combined Hepatitis A and Hepatitis B vaccine This PGD must be read in conjunction with the core PGD (Reference: NHSE(LR)/PGD/Core PGD for Immunisations),

More information

Hepatitis B: the burden. The worldwide impact of hepatitis B vaccination: A historical overview. Vaccination against Hepatitis B

Hepatitis B: the burden. The worldwide impact of hepatitis B vaccination: A historical overview. Vaccination against Hepatitis B The worldwide impact of hepatitis B : A historical overview Prof. Alessandro Zanetti Department of Public Health Microbiology Virology Università degli Studi di Milano, Milan, Italy Hepatitis B: the burden

More information

FREQUENTLY ASKED QUESTIONS ON PENTAVALENT

FREQUENTLY ASKED QUESTIONS ON PENTAVALENT FREQUENTLY ASKED QUESTIONS ON PENTAVALENT 1 Frequently asked questions on Pentavalent Two additional vaccines have been added to the DPT vaccine, namely total of 5 vaccines in one injection which is called

More information

Modifying the childhood immunisation schedule

Modifying the childhood immunisation schedule Modifying the childhood immunisation schedule With thanks to Dr. Marilyn Lansley for allowing adaptation and use of her presentations Vaccine Advice for CliniCians Service Objectives Understand the flexibility

More information

Hepatitis B. Epidemiology in New Zealand. Case definition. Clinical description. Laboratory test for diagnosis

Hepatitis B. Epidemiology in New Zealand. Case definition. Clinical description. Laboratory test for diagnosis Hepatitis B Epidemiology in New Zealand Risk factors for acute hepatitis B in New Zealand include overseas travel and sexual contact, as well as household contact with a chronic carrier. An estimated 1

More information

Perinatal Hepatitis B

Perinatal Hepatitis B Perinatal Hepatitis B MISTY HALL RN, BSN NURSE CONSULTANT AK IMMUNIZATION PROGRAM Perinatal Case Management Importance of Birth Dose to End Hepatitis B in Newborns was addressed yesterday Goals: Identify

More information

Community Psychiatric Nurse. Consultant Psychiatrist, Substance Misuse Services

Community Psychiatric Nurse. Consultant Psychiatrist, Substance Misuse Services PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF HEPATITIS A & B COMBINED VACCINE (TWINRIX ADULT VACCINE) BY REGISTERED NURSES WORKING IN THE COMMUNITY SUBSTANCE MISUSE TEAMS Version Number : 4

More information

GUIDE TO FOLLOW UP TESTING FOR BLOOD OR BODY FLUID EXPOSURES AND NEEDLESTICK INJURIES

GUIDE TO FOLLOW UP TESTING FOR BLOOD OR BODY FLUID EXPOSURES AND NEEDLESTICK INJURIES GUIDE TO FOLLOW UP TESTING FOR BLOOD OR BODY FLUID EXPOSURES AND NEEDLESTICK INJURIES Hepatitis B, Hepatitis C and HIV may be contracted through exposure to any body fluid, particularly blood. Follow up

More information

BP 4316 PERSONNEL HEPATITIS B IMMUNIZATION

BP 4316 PERSONNEL HEPATITIS B IMMUNIZATION PERSONNEL BP 4316 HEPATITIS B IMMUNIZATION All personnel, certificated and classified, employed in the Tehama County Department of Education who work with a student population which includes students with

More information

Immunisation is highly effective in preventing hepatitis B infection in babies and children.

Immunisation is highly effective in preventing hepatitis B infection in babies and children. Yo y b a B r u o u and Y B s i t i t a p He If you have hepatitis B and you are pregnant, planning a pregnancy, if you've just had a baby or have children already, this leaflet will give you information

More information

Antenatal Guidelines. No.10 Varicella Zoster Virus

Antenatal Guidelines. No.10 Varicella Zoster Virus Antenatal Guidelines No.10 Varicella Zoster Virus 90% of women attending antenatal clinics are immune to VZV The chickenpox rash is sufficiently distinctive to make a diagnosis without laboratory investigations

More information

Consultant Psychiatrist, Substance Misuse Services

Consultant Psychiatrist, Substance Misuse Services PATIENT GROUP DIRECTION (PGD) FOR THE ADMINISTRATION OF HEPATITIS A VACCINE (AVAXIM VACCINE) BY REGISTERED NURSES WORKING IN THE COMMUNITY SUBSTANCE MISUSE TEAMS Version Number : 4 Patient Group Direction

More information

INFANT IMMUNISATION GUIDELINES

INFANT IMMUNISATION GUIDELINES INFANT IMMUNISATION GUIDELINES For all immunisations it is imperative that parental consent is obtained prior to proceeding. Use the Immunisation Consent and Administration Form. Once administered, fax

More information

Factsheet: Hep C and Pregnancy, Babies and Children

Factsheet: Hep C and Pregnancy, Babies and Children Factsheet: Hep C and Pregnancy, Babies and Children For more information about anything in this factsheet, phone the Hepatitis Infoline on 1800 803 990 or go to www.hep.org.au or contact the Clinical Nurse

More information

HEPATITIS C IN PREGNANCY. Author/Reviewed by: Kate Drysdale, Clinical Nurse Specialist. Sally Abbatiello Burns, SPMW Vulnerable women Version: 2

HEPATITIS C IN PREGNANCY. Author/Reviewed by: Kate Drysdale, Clinical Nurse Specialist. Sally Abbatiello Burns, SPMW Vulnerable women Version: 2 Operations Directorate: Maternity and Children s Service Name of Guideline: HEPATITIS C IN PREGNANCY Guideline No: 244 Author/Reviewed by: Kate Drysdale, Clinical Nurse Specialist Blood Borne Viruses Sally

More information

Hepatitis B antenatal screening and newborn immunisation programme. Best practice guidance

Hepatitis B antenatal screening and newborn immunisation programme. Best practice guidance Hepatitis B antenatal screening and newborn immunisation programme Best practice guidance DH INFORMATION READER BOX Policy HR / Workforce Management Planning / Clinical Document Purpose Gateway Reference

More information

Executive summary of recommendations

Executive summary of recommendations MOH CLINICAL PRACTICE GUIDELINES 2/2011 Chronic Hepatitis B Infection College of Family Physicians, Singapore Academy of Medicine, Singapore Singapore Medical Association Executive summary of recommendations

More information

Management of infants born to an HIV Positive Mother

Management of infants born to an HIV Positive Mother SOUTHERN WEST MIDLANDS NEWBORN NETWORK Hereford, Worcester, Birmingham, Sandwell & Solihull Title Management of infants born to an HIV Positive Mother Author Dr Steve Welch Date Guideline Agreed: May 2009

More information

Occupational Exposures to Hepatitis B, C, and HIV: What you need to know W Y OMING DEPA R TMENT OF HEALTH

Occupational Exposures to Hepatitis B, C, and HIV: What you need to know W Y OMING DEPA R TMENT OF HEALTH Occupational Exposures to Hepatitis B, C, and HIV: What you need to know C OURTNEY SMITH, M PH C OMMUNICABLE DISEASE SURV E ILLANCE M A NAGER W Y OMING DEPA R TMENT OF HEALTH Objectives Discuss characteristics

More information

Selective testing for hepatitis A IgG may be cost effective in vaccination candidates? Dr. Fiona Wallace

Selective testing for hepatitis A IgG may be cost effective in vaccination candidates? Dr. Fiona Wallace Selective testing for hepatitis A IgG may be cost effective in vaccination candidates? Dr. Fiona Wallace Northern European Conference on Travel Medicine 5, Bergen, June 2014 Acknowledgements and Declarations

More information

Patient Group Direction for Varicella vaccine Version: Varicella Start Date: 01 May 2012 Expiry Date: 30 April 2014

Patient Group Direction for Varicella vaccine Version: Varicella Start Date: 01 May 2012 Expiry Date: 30 April 2014 Patient Group Direction for Varicella vaccine Version: Varicella 2012.1 Start Date: 01 May 2012 Expiry Date: 30 April 2014 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: NHS

More information

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic.

NICE Pathways bring together all NICE guidance, quality standards and other NICE information on a specific topic. bring together all NICE guidance, quality standards and other NICE information on a specific topic. are interactive and designed to be used online. They are updated regularly as new NICE guidance is published.

More information

Patient Group Direction for Combined Hepatitis A & B vaccine Version: Hep A + B Start Date: 1 st January 2016 Expiry Date: 31 st December 2018

Patient Group Direction for Combined Hepatitis A & B vaccine Version: Hep A + B Start Date: 1 st January 2016 Expiry Date: 31 st December 2018 Patient Group Direction for Combined Hepatitis A & B vaccine Version: Hep A + B 2016.1 Start 1 st January 2016 Expiry 31 st December 2018 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS:

More information

The ABCs of Viral Hepatitis

The ABCs of Viral Hepatitis The ABCs of Viral Hepatitis Prepared by Mark Stanford, Ph.D. 2008 VIRAL HEPATITIS A (HAV) Description Hepatitis A is a liver disease caused by the hepatitis A virus. Hepatitis A can affect anyone. In the

More information

SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS Registration No. 1B 1/45 Importer / Manufacturer: GPO-MBP SUMMARY OF PRODUCT CHARACTERISTICS 1. ME OF THE MEDICAL PRODUCT HEPATITIS B VACCINE, RECOMBINT 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml

More information

UCSF Communicable Disease Surveillance and Vaccination Policy

UCSF Communicable Disease Surveillance and Vaccination Policy Office of Origin: Occupational Health Program I. PURPOSE To provide a sustainable, healthy and safe working environment for UCSF research laboratory staff, and animal research care staff and to prevent

More information

HyperHEP B. Please read this leaflet carefully before you start using HyperHEP B.

HyperHEP B. Please read this leaflet carefully before you start using HyperHEP B. New Zealand Consumer Medicine Information HyperHEP B Hepatitis B Immunoglobulin (Human) 220 IU/mL, Solution for Intramuscular Injection What is in this leaflet Please read this leaflet carefully before

More information

Neonatal Management Plans for Infants Exposed to Drugs or Alcohol Guideline (GL1009)

Neonatal Management Plans for Infants Exposed to Drugs or Alcohol Guideline (GL1009) Neonatal Management Plans for Infants Exposed to Drugs or Alcohol Guideline (GL1009) Approval Approval Group Job Title, Chair of Committee Date Maternity & Children s Services Clinical Governance Committee

More information

Women, Children s and Sexual Health Division Maternity Services. MMR / Rubella Vaccine for Postnatal Woman

Women, Children s and Sexual Health Division Maternity Services. MMR / Rubella Vaccine for Postnatal Woman Women, Children s and Sexual Health Division Maternity Services Guideline: MMR - Rubella Vaccination for Postnatal Woman 1. Introduction Rubella vaccine is usually given in childhood along with the measles

More information

PACKAGE LEAFLET FH/PIL/

PACKAGE LEAFLET FH/PIL/ PACKAGE LEAFLET 1 PACKAGE LEAFLET: INFORMATION FOR THE USER HepBQuin 100 IU solution for injection HepBQuin 150 IU solution for injection HepBQuin 500 IU solution for injection Human hepatitis B immunoglobulin

More information

Pathway for Going Viral week

Pathway for Going Viral week Pathway for Going Viral week Going Viral Lead: Dr Chloe Orkin Infection & Immunity (ECAM) BBV Testing Facilitator Dr Emma Wallis On Call HIV SpR 07824 864814 (Mon-Fri 9-5) Out of hours: via switchboard

More information

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND EPIDEMIOLOGY OF HEPATITIS B IN IRELAND Table of Contents Acknowledgements 3 Summary 4 Introduction 5 Case Definitions 6 Materials and Methods 7 Results 8 Discussion 11 References 12 Epidemiology of Hepatitis

More information

Hepatitis B Virus. Elizabeth Draper, RN Nurse Consultant NC Immunization Branch NC Division of Public Health

Hepatitis B Virus. Elizabeth Draper, RN Nurse Consultant NC Immunization Branch NC Division of Public Health Hepatitis B Virus Elizabeth Draper, RN Nurse Consultant NC Immunization Branch NC Division of Public Health Learning Objectives Recognize modes of transmission Apply knowledge of Hepatitis B serologies

More information

Table 3.3.1: Recommendations for vaccination in pregnancy (see also disease-specific chapters in Part 4)

Table 3.3.1: Recommendations for vaccination in pregnancy (see also disease-specific chapters in Part 4) Table 3.3.1: Recommendations for vaccination in pregnancy (see also disease-specific chapters in Part 4) Vaccines routinely recommended in pregnancy Inactivated vaccines Recommendation Comments Influenza

More information

Vaccines Against Varicella and Hepatitis B Ch 13, 14 and 15. Varicella Zoster Virus

Vaccines Against Varicella and Hepatitis B Ch 13, 14 and 15. Varicella Zoster Virus Vaccines Against Varicella and Hepatitis B Ch 13, 14 and 15 Varicella Zoster Virus Herpesvirus (DNA) Primary infection results in varicella (chickenpox) Recurrent infection results in herpes zoster (shingles)

More information

Summary of Key Points

Summary of Key Points Summary of Key Points Tetanus vaccines: WHO position paper February 2017 1 Background l Tetanus is an acute infectious disease caused by toxigenic strains of the bacterium Clostridium tetani (C. tetani).

More information

August 2012 GPC. General Practitioners Committee. Focus on hepatitis B immunisations. Guidance for GPs

August 2012 GPC. General Practitioners Committee. Focus on hepatitis B immunisations. Guidance for GPs August 2012 GPC General Practitioners Committee Focus on hepatitis B immunisations Guidance for GPs Focus on hepatitis B immunisations Introduction The clinical benefits of hepatitis B immunisation are

More information

Are Booster Doses of Hepatitis B Vaccine Necessary?

Are Booster Doses of Hepatitis B Vaccine Necessary? Are Booster Doses of Hepatitis B Vaccine Necessary? Current CDC Recommendations And Gaps in Knowledge Division of Viral Hepatitis Centers for Disease Control and Prevention, USA Current United States Recommendations

More information

POST EXPOSURE PROPHYLAXI S

POST EXPOSURE PROPHYLAXI S Departments of Infectious Diseases & Emergency Medicine POST EXPOSURE PROPHYLAXI S QUI CK GUI DE FOR EMERGENCY DEPT Adapted from Irish National PEP Guidelines and St James s Hospital GUIDE Clinic/Emergency

More information

COFM Immunization Policy

COFM Immunization Policy COFM Immunization Policy COUNCIL OF ONTARIO FACULTIES OF MEDICINE An affiliate of the Council of Ontario Universities This policy, based on the recommendations of an expert panel and reviewed annually,

More information

Hepatitis C. What is Hepatitis C? Who gets hepatitis C? How is hepatitis C spread?

Hepatitis C. What is Hepatitis C? Who gets hepatitis C? How is hepatitis C spread? Hepatitis C What is Hepatitis C? Hepatitis C is a liver disease caused by infection with the hepatitis C virus. Who gets hepatitis C? Anyone can get hepatitis C, but those at greatest risk are: Individuals

More information

Immunisation schedule of the Spanish Association of Paediatrics: 2014 recommendations

Immunisation schedule of the Spanish Association of Paediatrics: 2014 recommendations VACCINE Table 1. Spanish Association of Paediatrics Immunisation Schedule. Recommendations of the Advisory Committee on Vaccines Age in months Age in years 0 2 4 6 12-15 15-18 2-3 4-6 11-12 Hepatitis B

More information

PUBLIC HEALTH FOLLOW-UP OF HEPATITIS B IN THE WINNIPEG HEALTH REGION

PUBLIC HEALTH FOLLOW-UP OF HEPATITIS B IN THE WINNIPEG HEALTH REGION PUBLIC HEALTH FOLLOW-UP OF HEPATITIS B IN THE WINNIPEG HEALTH REGION This document provides the operational process for the public health follow-up of. It is intended as a companion document to the Manitoba

More information

Indicate whether the case had jaundice. If not known or unavailable then select the Unknown option.

Indicate whether the case had jaundice. If not known or unavailable then select the Unknown option. HBC-1 HEPATITIS B, C, NOS Disease name Disease Indicate whether the case is hepatitis B, C or NOS (Not Otherwise Specified). Select hepatitis NOS for cases of hepatitis D, hepatitis E or if the type of

More information

2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Active ingredient: Human hepatitis B immunoglobulin

2. QUALITATIVE AND QUANTITATIVE COMPOSITION. Active ingredient: Human hepatitis B immunoglobulin 1 NAME OF THE MEDICINAL PRODUCT Hepatitis B Immunoglobulin P Behring Solution for injection for intramuscular use 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active ingredient: Human hepatitis B immunoglobulin

More information

Immunisation against meningococcal B disease for infants aged from two months

Immunisation against meningococcal B disease for infants aged from two months Immunisation against meningococcal B disease for infants aged from two months Practice Nurse Training Information July / August 2015 South West Screening & Immunisation Team Meningococcal B programme Routine

More information

What is the risk of infection after an occupational exposure? CNM/HWPS Post BBP Exposure Fact Sheet, 2016

What is the risk of infection after an occupational exposure? CNM/HWPS Post BBP Exposure Fact Sheet, 2016 Healthcare personnel are at risk for occupational exposure to bloodborne pathogens, including hepatitis B virus (HBV), hepatitis C virus (HCV), and human immunodeficiency virus (HIV). Exposures occur through

More information

For the use of a Registered Medical Practitioner or a Hospital or a Laboratory only

For the use of a Registered Medical Practitioner or a Hospital or a Laboratory only For the use of a Registered Medical Practitioner or a Hospital or a Laboratory only Easyfive Pentavalent Vaccine For Intramuscular Injection only For Active Immunization against Diphtheria, Tetanus, Whooping

More information

ALBERTA IMMUNIZATION POLICY GUIDELINES

ALBERTA IMMUNIZATION POLICY GUIDELINES ALBERTA IMMUNIZATION POLICY GUIDELINES Hepatitis Vaccines. Hepatitis A Vaccines Refer to the vaccine product monograph and the Canadian Immunization Guide for further Product monographs are available on

More information

PERINATAL HEPATITIS B & C, PHILADELPHIA

PERINATAL HEPATITIS B & C, PHILADELPHIA PERINATAL HEPATITIS B & C, PHILADELPHIA Danica Kuncio, MPH Viral Hepatitis Epidemiologist Philadelphia Dept. of Public Health NASTAD TA Meeting October 20 th, 2015 PERINATAL HBV What We Know Without PEP

More information

Measles Disease: Q & A

Measles Disease: Q & A What causes measles? Measles disease is caused by a virus. This virus infects humans, causing measles disease in anyone who is not immunized or who has not previously had measles. What are the symptoms

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) CORE SPC FOR HUMAN VARICELLA IMMUNOGLOBULIN FOR INTRAMUSCULAR USE (CPMP/BPWG/3726/02)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) CORE SPC FOR HUMAN VARICELLA IMMUNOGLOBULIN FOR INTRAMUSCULAR USE (CPMP/BPWG/3726/02) European Medicines Agency Human Medicines Evaluation Unit London, 27 July 2005 CPMP/BPWG/3726/02 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) CORE SPC FOR HUMAN VARICELLA IMMUNOGLOBULIN FOR INTRAMUSCULAR

More information

Hepatitis B Training for Patient Navigators/Health Educators

Hepatitis B Training for Patient Navigators/Health Educators Hepatitis B Training for Patient Navigators/Health Educators Overview What is the liver? The liver is the largest and one of the most important organs in the body. The liver stores fats, sugars, vitamins

More information

Hepatitis B Vaccine Studies in Alaska. Brian J McMahon Viral Hepatitis Program Alaska Native Medical Center

Hepatitis B Vaccine Studies in Alaska. Brian J McMahon Viral Hepatitis Program Alaska Native Medical Center Hepatitis B Vaccine Studies in Alaska Brian J McMahon Viral Hepatitis Program Alaska Native Medical Center Long-term HB Vaccine and Booster Studies Conducted in Alaska Vax Demo Vax Demo Booster

More information

I B2.4. Design of the patient information leaflet for VariQuin

I B2.4. Design of the patient information leaflet for VariQuin (English translation of official Dutch version) I B2.4. Design of the patient information leaflet for VariQuin Information for the Patient: Read this package leaflet carefully when you have some time to

More information

Waning Immunity to Plasma- derived Hepatitis B Vaccine and the Need for Boosters 15 Years After Neonatal Vaccination. Hepatology 2004;40:

Waning Immunity to Plasma- derived Hepatitis B Vaccine and the Need for Boosters 15 Years After Neonatal Vaccination. Hepatology 2004;40: Waning Immunity to Plasma- derived Hepatitis B Vaccine and the Need for Boosters 15 Years After Neonatal Vaccination Hepatology 2004;40:1415-1420 1420 Introduction Taiwan started a national program of

More information

DEPARTMENT OF HEALTH Rheynn Slaynt. Immunoglobulin Policy

DEPARTMENT OF HEALTH Rheynn Slaynt. Immunoglobulin Policy DEPARTMENT OF HEALTH Rheynn Slaynt Immunoglobulin Policy February 2012 Contents 1. Introduction... 3 2. Rabies Immunoglobulin (RIG)... 4 2.1 Indication for use... 4 2.2 Access to the immunoglobulin...

More information

INDICATIONS FOR USE OF ANTI-D IMMUNOGLOBULIN

INDICATIONS FOR USE OF ANTI-D IMMUNOGLOBULIN The Guidelines for use of Anti-D Immunoglobulin have been prepared by NZ Blood Service for use by Midwives and Medical Practitioners involved in caring for pregnancies or obstetric practice in New Zealand.

More information

A Guide to your Vaccination & Screening Clinic Appointment

A Guide to your Vaccination & Screening Clinic Appointment City University: School of Health Sciences A Guide to your Vaccination & Screening Prepared by OHWorks Ltd 20 July 2016 1 Dear Student We are an independent Occupational Health service. We are undertaking

More information

Mother s blood test to check her unborn baby s blood group

Mother s blood test to check her unborn baby s blood group Mother s blood test to check her unborn baby s blood group This leaflet explains why it is important to have a blood test to check the baby s blood group, so that only those who need it, receive anti-d

More information

160S01105, Page 1 of 7. Human Hepatitis B Immunoglobulin, solution for intramuscular injection.

160S01105, Page 1 of 7. Human Hepatitis B Immunoglobulin, solution for intramuscular injection. 160S01105, Page 1 of 7 New Zealand Data Sheet Hepatitis B Immunoglobulin-VF NAME OF THE MEDICINE Human Hepatitis B Immunoglobulin, solution for intramuscular injection. DESCRIPTION Hepatitis B Immunoglobulin-VF

More information

Hepatitis End of Module Quiz (9 Questions)

Hepatitis End of Module Quiz (9 Questions) Hepatitis End of Module Quiz (9 Questions) 1. Which of the following is true regarding hepatitis? A. Hepatitis means inflammation B. Hepatitis can result from both infectious and non-infectious causes

More information

HBC-1. If the case had jaundice, tick the Yes box. If not, tick the No box. If not known or unavailable then tick the Unknown box.

HBC-1. If the case had jaundice, tick the Yes box. If not, tick the No box. If not known or unavailable then tick the Unknown box. HBC-1 HEPATITIS B, C, NOS Disease Name Disease Indicate whether the case is hepatitis B, C or NOS (Not Otherwise Specified). Use NOS for cases of hepatitis D or E or if the type of hepatitis has not been

More information

Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners

Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners Vaccination against pertussis (whooping cough) - the replacement of Repevax with Boostrix -IPV an update for registered healthcare practitioners Questions and Answers May 2014 Health Protection Scotland

More information

Hepatitis Vaccination Policy

Hepatitis Vaccination Policy Hepatitis Vaccination Policy Purpose To outline requirements for Hepatitis Vaccinations Scope All operational levels of Life Saving Victoria Policy Background Hepatitis is a highly infectious disease.

More information

MANAGEMENT OF INFANTS BORN TO HIV POSITIVE MOTHERS

MANAGEMENT OF INFANTS BORN TO HIV POSITIVE MOTHERS MANAGEMENT OF INFANTS BORN TO HIV POSITIVE MOTHERS Introduction Perinatal management of infants born to HIV-infected mothers requires a coordinated multidisciplinary team approach. The consultant leads

More information

Trust Guideline for screening infants and children at risk of Hepatitis C infection

Trust Guideline for screening infants and children at risk of Hepatitis C infection Trust Guideline for screening infants and children at risk of Hepatitis C infection A clinical guideline recommended for use In: By: For: Key words: Written by: Supported by: Approved by: NICU and maternity

More information

Package leaflet: Information for the user. HBVAXPRO 5 micrograms, suspension for injection in pre-filled syringe Hepatitis B vaccine (rdna)

Package leaflet: Information for the user. HBVAXPRO 5 micrograms, suspension for injection in pre-filled syringe Hepatitis B vaccine (rdna) Package leaflet: Information for the user HBVAXPRO 5 micrograms, suspension for injection in pre-filled syringe Hepatitis B vaccine (rdna) Read all of this leaflet carefully before you or your child is

More information

TESTING AND MANAGEMENT. Dr Nicole Allard GP Cohealth, Joslin Clinic, West Footscray PhD student, Epidemiology Unit VIDRL

TESTING AND MANAGEMENT. Dr Nicole Allard GP Cohealth, Joslin Clinic, West Footscray PhD student, Epidemiology Unit VIDRL TESTING AND MANAGEMENT Dr Nicole Allard GP Cohealth, Joslin Clinic, West Footscray PhD student, Epidemiology Unit VIDRL Disclosure and acknowledgments No conflicts of interest Board Member of Hepatitis

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) European Medicines Agency Human Medicines Evaluation Unit London, 27 July 2005 CPMP/BPWG/3732/02 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) CORE SPC FOR HUMAN TICK-BORNE ENCEPHALITIS IMMUNOGLOBULIN

More information

Epidemiology. Update Chronic Hepatitis B Infection in Pregnant Women KEY FINDINGS Hennepin County Key Findings. April 2007

Epidemiology. Update Chronic Hepatitis B Infection in Pregnant Women KEY FINDINGS Hennepin County Key Findings. April 2007 Epidemiology April 2007 Update Chronic Hepatitis B Infection in Pregnant Women KEY FINDINGS Hennepin County Key Findings During 2001 2006, pregnant women infected with HBsAg were most often from the following

More information

New York State Department of Health Immunization Program Combined Hepatitis A and B Vaccine Dosing Schedule Policy

New York State Department of Health Immunization Program Combined Hepatitis A and B Vaccine Dosing Schedule Policy New York State Department of Health Immunization Program Combined Hepatitis A and B Vaccine Dosing Schedule Policy Policy Statement The accelerated four-dose schedule for combined hepatitis A and B vaccine

More information

Part Five Screening for Infectious diseases in pregnancy

Part Five Screening for Infectious diseases in pregnancy Patient Pathway: Screening for Communicable Diseases in Pregnancy Screening to occur as early as possible during pregnancy, but can be done at any time, as soon as a woman arrives for care Provide and

More information

Hepatitis B: What Hospitals Need to Do to Protect Newborns. A resource for birthing institutions to prevent perinatal transmission

Hepatitis B: What Hospitals Need to Do to Protect Newborns. A resource for birthing institutions to prevent perinatal transmission Give birth to the end of Hep B : A resource for birthing institutions to prevent perinatal transmission Prepared by the Immunization Action Coalition (IAC) Agenda I. Welcome and Agenda II. III. IV. Debra

More information

Patient Group Direction for Combined Hepatitis A and Typhoid vaccine Version: HepA-Typhoid Start Date:1 st May 2013 Expiry Date:30 th April 2015

Patient Group Direction for Combined Hepatitis A and Typhoid vaccine Version: HepA-Typhoid Start Date:1 st May 2013 Expiry Date:30 th April 2015 Patient Group Direction for Combined Hepatitis A and Typhoid vaccine Version: HepA-Typhoid-20131 Start Date:1 st May 2013 Expiry Date:30 th April 2015 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE

More information

Measles Vaccine Update

Measles Vaccine Update Measles Vaccine Update Tina Q. Tan, MD Professor of Pediatrics Northwestern University Feinberg School of Medicine Pediatric Infectious Diseases Attending Ann & Robert H. Lurie Children s Hospital, Chicago,

More information

Hepatitis B immunisation for people with Chronic Kidney Disease

Hepatitis B immunisation for people with Chronic Kidney Disease Oxford Kidney Unit Hepatitis B immunisation for people with Chronic Kidney Disease Information for patients What is hepatitis B? Hepatitis B is a serious inflammation of the liver that is caused by a viral

More information